García-Compean D, Cortés C

Language: English
References: 21
Page: 100-103
PDF size: 41.72 Kb.

Text Extraction

Transjugular liver biopsy was first reported in 1967. Since then, this technique has been broadly performed in many medical centers around the world. The number of its indications has increased, and by modifying the needles, the quality of the liver tissue sample has improved. The advantage of transjugular biopsy is that it can be performed in patients in whom the use of percutaneous biopsy is contraindicated Indications for transjugular liver biopsy are, precisely, most of the contraindications for percutaneous liver biopsy. This fact increases the number of patients that can benefit from this procedure.
In most cases, the procedure is successfully performed. . Minor complications may occur in 1% to 15% and major complications (perforation of the hepatic capsule, cholangitis, and intra-peritoneal bleeding) are observed in 1-3% of the cases. Mortality related to the procedure varies form 0.2 to 0.3%.
It has been reported that diagnosis yielded by transjugular liver biopsy induced changes of treatment in 50% of patients with an acute hepatic illness, in 62% of the patients with a chronic hepatic illness, and in 87% of the patients with liver transplants.
In conclusion, transjugular liver biopsy is a useful procedure in the diagnosis of hepatic diseases. Its success rate is high; it is a very safe procedure because complications and mortality are rare; and it is well tolerated by patients.

REFERENCES

1. Van Leewen DJ, Wilson L, Crow OR. Liver biopsy in the mid-1990: questions and answers. Semin Liver Dis 1995; 15: 340-359.

2. Bravo A, Sunil G, Sheth M, Chopra S. Liver biopsy. N Eng J Med 2001; 344: 495-500.

3. Garcia-Compean D, Mundo F, Uribe M. Transjugular liver biopsy in patients with severe delay in prothrombin time and massive ascites. Gastroenterology 1986; 90: A1423.

4. Van E, Kamath PS, Gostout Ch, Heith J. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc 1999; 50: 536-542.

5. Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 1997; 25: 118.

6. McGill DB, Rakela J, Zinsmeister AR, et al. A 21 year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396.

7. Bañares R, Alonso S. Biopsia hepática transyugular, revisión técnica diagnóstica. Gastroenterología Hepatología continuada 2001; 1(1): 27-9.

8. Abreu L. Gastroenterología. Endoscopia diagnóstica y terapéutica. Ed Eurobook; pag. 440-42

9. Lebrec D, Goldgarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy. An experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982; 83: 338-340.

10. Bass N, Francis YK. Transjugular procedures. Gastrointest Endosc Clin of North Am 2001; 11,1: 131-161.

11. Mc Affe JH, Keefe Eb, Lee RG. Transjugular liver biopsy. Hepatology 1992; 15: 726-732.

12. Trejo R, Alvarez W, Garcia-Pagan JC, Feu F, Escorsell A, Brugera M, Bosch J, Rodes J. The applicability and diagnostic effectiveness of transjugular liver biopsy. Med Clin (Barc) 1996; 107(14): 521-3

13. Bañares R, Alonso S., Catalina MV, Casado M, Rincón D. Randomized controlled trial of aspiration needle versus automated biopsy device for transjugular liver biopsy. J Vasc Radiol 2001; 12: 583-7.

14. Sada PN, Ramakrishna B, Thomas CD, Gavil S. Transjugular liver biopsy: a comparison of aspiration and trucut techniques. Liver 1997; 17(5): 257-9

15. Kardache M, Soyer P, Boudiaf M. Transjugular liver biopsy with an automated device. Radiology 1997; 204: 369-72.

16. De Hoyos A, Loredo ML, Martínez-Ríos MA, Gil MR. Transjugular liver biopsy in 52 patients with an automated trucut-type needle. Dig Dis Sci 1999; 44: 177-80.

17. Bories P, Chaker W, Mirouze D, Bauret P, Aubin JP, Garcia Compean D, Michel H. Interet de l’abord veineux transjugulaire du foie dans le diagnostic de la cirrhose- 333 cas. Presse Med 1985; 14: 1543-1545.

18. Papatheodoridis GV, Patch D, Watkinson A, Tibballs J, Burroughs AK. Transjugular liver biopsy in the 1990s: a 2-year audit. Aliment Pharmacol Ther 1999; 13: 603-608.

19. Parera A, Bañeras R, Alvarez J, Casariego JA, Carneros M, Salcedo E. Utilidad de la biopsia hepática transyugular en la evaluación de la hepatopatía en el paciente candidato a transplante cardiaco. Gastroenterol Hepatol 1999; 22: 67-71.

20. Romero M, Bañeras R, Salcedo M, Alvarez E. Valor diagnóstico de la biopsia hepática transyugular en pacientes receptores de transplante hepático. Gastroenterol Hepatol 1999; 22: 493-496.

21. Morales J, Campistol J. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 1343-1353.